Introduction: This study evaluated whether comorbidities such as genetic conditions, other congenital anomalies, infection, and other exposures impact the mortality rate and/or neurologic outcomes of patients with congenital ventriculomegaly. Methods: This was a retrospective cohort study that assessed the mortality rate and developmental delay of 91 patients diagnosed with congenital ventriculomegaly followed at Cincinnati Children’s Hospital Medical Center between January 1, 2010, and December 31, 2020. Results: Of the 91 patients included in the study, 20 (22.0%) had a genetic diagnosis. The mortality rate was higher for patients with a genetic diagnosis compared to those without a genetic diagnosis (p = 0.022), as was the rate of developmental delay (p = 0.026). The presence of comorbidities (confirmed genetic condition, confirmed maternal exposures or infections, and/or additional anomalies) was not associated with an increased risk of mortality nor developmental delay. Conclusions: Patients diagnosed with congenital ventriculomegaly and a genetic condition have a significantly higher risk of early mortality and developmental delay compared to those without a genetic diagnosis. Therefore, diagnostic genetic testing should be considered after identification of congenital ventriculomegaly to facilitate counseling about prognosis and care management.

1.
Dewan
MC
,
Rattani
A
,
Mekary
R
,
Glancz
LJ
,
Yunusa
I
,
Baticulon
RE
, et al
.
Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis
.
J Neurosurg
.
2019
;
130
(
4
):
1065
79
.
2.
Kline-Fath
BM
,
Arroyo
MS
,
Calvo-Garcia
MA
,
Horn
PS
,
Thomas
C
.
Congenital aqueduct stenosis: progressive brain findings in utero to birth in the presence of severe hydrocephalus
.
Prenat Diagn
.
2018
;
38
(
9
):
706
12
.
3.
Peiro
JL
,
Fabbro
MD
.
Fetal therapy for congenital hydrocephalus-where we came from and where we are going
.
Childs Nerv Syst
.
2020
;
36
(
8
):
1697
712
.
4.
Moritake
K
,
Nagai
H
,
Miyazaki
T
,
Nagasako
N
,
Yamasaki
M
,
Sakamoto
H
, et al
.
Analysis of a nationwide survey on treatment and outcomes of congenital hydrocephalus in Japan
.
Neurol Med Chir
.
2007
;
47
(
10
):
453
61
.
5.
Tonetti
DA
,
Richter
B
,
Andrews
E
,
Xu
C
,
Emery
SP
,
Greene
S
.
Clinical outcomes of isolated congenital aqueductal stenosis
.
World Neurosurg
.
2018
;
114
:
e976
81
.
6.
Gaglioti
P
,
Danelon
D
,
Bontempo
S
,
Mombrò
M
,
Cardaropoli
S
,
Todros
T
.
Fetal cerebral ventriculomegaly: outcome in 176 cases
.
Ultrasound Obstet Gynecol
.
2005
;
25
(
4
):
372
7
.
7.
Emery
SP
,
Greene
S
,
Hogge
WA
.
Fetal therapy for isolated aqueductal stenosis
.
Fetal Diagn Ther
.
2015
;
38
(
2
):
81
5
.
8.
von Koch
CS
,
Gupta
N
,
Sutton
LN
,
Sun
PP
.
In utero surgery for hydrocephalus
.
Childs Nerv Syst
.
2003
;
19
(
7–8
):
574
86
.
9.
Emery
SP
,
Hogge
WA
,
Hill
LM
.
Accuracy of prenatal diagnosis of isolated aqueductal stenosis
.
Prenat Diagn
.
2015
;
35
(
4
):
319
24
.
10.
Harstad
E
.
Caring for your baby and young child
. 5th ed;
2005
.
11.
Cai
M
,
Huang
H
,
Xu
L
,
Lin
N
.
Classifying and evaluating fetuses with ventriculomegaly in genetic etiologic studies
.
Front Genet
.
2021
;
12
:
682707
.
12.
Etchegaray
A
,
Juarez-Peñalva
S
,
Petracchi
F
,
Igarzabal
L
.
Prenatal genetic considerations in congenital ventriculomegaly and hydrocephalus
.
Childs Nerv Syst
.
2020
;
36
(
8
):
1645
60
.
13.
Petrovski
S
,
Aggarwal
V
,
Giordano
JL
,
Stosic
M
,
Wou
K
,
Bier
L
, et al
.
Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study
.
Lancet
.
2019
;
393
(
10173
):
758
67
.
14.
Swaggart
KA
,
Swarr
DT
,
Tolusso
LK
,
He
H
,
Dawson
DB
,
Suhrie
KR
.
Making a genetic diagnosis in a level IV neonatal intensive care unit population: who, when, how, and at what cost
.
J Pediatr
.
2019
;
213
:
211
7.e4
.
15.
Mustafa
HJ
,
Sambatur
EV
,
Barbera
JP
,
Pagani
G
,
Yaron
Y
,
Baptiste
CD
, et al
.
Diagnostic yield with exome sequencing in prenatal severe bilateral ventriculomegaly: a systematic review and meta-analysis
.
Am J Obstet Gynecol MFM
.
2023
;
5
(
9
):
101048
.
16.
Hill
LM
,
Breckle
R
,
Thomas
ML
,
Fries
JK
.
Polyhydramnios: ultrasonically detected prevalence and neonatal outcome
.
Obstet Gynecol
.
1987
;
69
(
1
):
21
5
.
17.
Bauserman
M
,
Nathan
R
,
Lokangaka
A
,
McClure
EM
,
Moore
J
,
Ishoso
D
, et al
.
Polyhydramnios among women in a cluster-randomized trial of ultrasound during prenatal care within five low and low-middle income countries: a secondary analysis of the first look study
.
BMC Pregnancy Childbirth
.
2019
;
19
(
1
):
258
.
18.
Martin
JA
,
Hamilton
BE
,
Osterman
MJK
,
Driscoll
AK
.
Births: final data for 2019
.
Natl Vital Stat Rep
.
2021
;
70
(
2
):
1
51
.
19.
Harrison
W
,
Goodman
D
.
Epidemiologic trends in neonatal intensive care, 2007-2012
.
JAMA Pediatr
.
2015
;
169
(
9
):
855
62
.
20.
Braun
D
,
Braun
E
,
Chiu
V
,
Burgos
AE
,
Gupta
M
,
Volodarskiy
M
, et al
.
Trends in neonatal intensive care unit utilization in a large integrated health care system
.
JAMA Netw Open
.
2020
;
3
(
6
):
e205239
.
21.
Bjorland
PA
,
Øymar
K
,
Ersdal
HL
,
Rettedal
SI
.
Incidence of newborn resuscitative interventions at birth and short-term outcomes: a regional population-based study
.
BMJ Paediatr Open
.
2019
;
3
(
1
):
e000592
.
22.
Haidari
ES
,
Lee
HC
,
Illuzzi
JL
,
Phibbs
CS
,
Lin
H
,
Xu
X
.
Hospital variation in admissions to neonatal intensive care units by diagnosis severity and category
.
J Perinatol
.
2021
;
41
(
3
):
468
77
.
You do not currently have access to this content.